The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate (ADC) therapy.
 
Lu Si
Honoraria - MSD; Novartis; Oriengene; Roche China; Shanghai Junshi Biosciences
 
Jia Jia
No Relationships to Disclose
 
Lili Mao
Honoraria - MSD; Novartis; Shanghai Junshi BioSciences
Research Funding - MSD
 
Jing Lin
No Relationships to Disclose
 
Pei Yuan
No Relationships to Disclose
 
Wen Yu Li
No Relationships to Disclose
 
Jie Dai
No Relationships to Disclose
 
Zhong-Wu Li
No Relationships to Disclose
 
Xue Bai
No Relationships to Disclose
 
Caili Li
No Relationships to Disclose
 
Lei Guo
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose
 
Jianming Ying
No Relationships to Disclose
 
Jun Guo
No Relationships to Disclose